Please assess the completion status of the following clinical trial:

Trial Title: A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
The following eligibility criteria pertain to patients enrolling into PART 2 of the study:~Inclusion:~* Have a histologically confirmed diagnosis of high grade serous or Grade 2 or Grade 3 endometrioid epithelial ovarian, fallopian tube, or primary peritoneal cancer~* Received at least 3 prior chemotherapy regimens. Non-chemotherapy regimens and maintenance therapies administered as single agent treatment will not count as a chemotherapy regimen~* Relapsed/progressive disease as confirmed by CT scan~* Have biopsiable and measurable disease. Note: biopsy is optional for patients known to harbor a deleterious gBRCA mutation~* Have sufficient archival formalin-fixed paraffin-embedded (FFPE) tumor tissue available for planned analyses~Exclusion:~* History of prior cancers except for those that have been curatively treated, with no evidence of cancer currently (provided all chemotherapy was completed \>6 months prior and/or bone marrow transplant \>2 years prior to first dose of rucaparib).~* Prior treatment with any PARP inhibitor~* Symptomatic and/or untreated central nervous system metastases~* Pre-existing duodenal stent and/or any other gastrointestinal disorder or defect that would, in the opinion of the Investigator, interfere with absorption of rucaparib~* Hospitalization for bowel obstruction within 3 months prior to enrollment

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ovarian cancer (Type: EXPERIMENTAL): rucaparib

Based on this trial design, predict the completion outcome and termination type (if applicable).